Vitality Watch

Dossier clinicaltrials trial early 28-jul-2026
Small or early-phase human trial or pilot study

β-glucan and Exercise on Musculoskeletal Function in Sarcopenic Adults

Key claim: A planned randomized, double-blind, placebo-controlled trial will test whether Aureobasidium pullulans–produced β-glucan plus regular combined exercise improves muscle strength, mass, function, and biomarkers over 12 weeks in adults with relative sarcopenia.

Abstract

The investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Aureobasidium pullulans produced β-glucan and regular combined exercise on muscle strength, muscle mass, muscle function, and biomarkers in adults with relative sarcopenia for 12 weeks.

Why this matters

A planned randomized, double-blind, placebo-controlled trial will test whether Aureobasidium pullulans–produced β-glucan plus regular combined exercise improves muscle strength, mass, function, and biomarkers over 12 weeks in adults with relative sarcopenia.

Source

Link

Briefing card

β-glucan and Exercise on Musculoskeletal Function in Sarcopenic Adults
Stage: trial early · clinicaltrials · 28-jul-2026

A planned randomized, double-blind, placebo-controlled trial will test whether Aureobasidium pullulans–produced β-glucan plus regular combined exercise improves muscle strength, mass, function, and biomarkers over 12 weeks in adults with relative sarcopenia.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06629805

build build 880 · 2bcef25 · 2026-11-18